Catalyst Wire Dossier Catalyst Wire Dossier

bempeg with pembrolizumab

· Nektar Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for bempeg with pembrolizumab, covering 2022-12-15 to 2022-12-15. Get the full timeline:

Most recent: Clinical Trial Update: BEMPEG With Pembrolizumab vs Pembrolizumab Alone in Patients With Metastatic or Recurrent HNSCC (PROPEL-36) [Phase 2, Phase 3]

See pricing